Investor Ideas #Potcasts 517, #Cannabis News and #Stocks on the Move; (TSX: $APHA.TO) (Nasdaq: $APHA) (TSXV: $N.V) (TSX: $VLNS.TO) (CSE: $PULL.C)
Delta, Kelowna, BC, January 14, 2020 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, www.potcasts.ca release today’s podcast edition of cannabis news and stocks to watch plus insight from thought leaders and experts.
Listen to the podcast:
https://www.investorideas.com/Audio/Podcasts/2021/011421-StocksToWatch.mp3
Read this in full
at https://www.investorideas.com/news/2021/cannabis-potcasts/01141APHA-N-VLNS-PULL.asp
Hear the investor ideas potcast on Spotify
Hear Investor ideas cannabis potcast on iTunes
Today’s podcast overview/transcript:
Good
afternoon and welcome to another episode of Investorideas.com
"Potcast" featuring cannabis news, stocks to watch as well as
insights from thought leaders and experts.
In
today’s podcast we will be looking at a few public company announcements.
Aphria
Inc.
(TSX:
APHA) (Nasdaq:
APHA), a leading global cannabis-lifestyle consumer
packaged goods company inspiring and empowering the worldwide community to live
their very best life, today
reported its financial results for the second quarter and six
months ended November 30, 2020. All amounts are expressed in Canadian dollars,
unless otherwise noted and except for per gram, kilogram, kilogram equivalents,
and per share amounts.
"We are pleased with our second
quarter results which reflect the strength of our diversified global cannabis
and consumer packaged goods businesses," said Irwin D. Simon, Chairman and
Chief Executive Officer. "Our market leading adult-use cannabis brands and
sales remained strong and our international medical cannabis sales are off to a
solid start. We also advanced our long-term vision for building a global
cannabis life-style consumer packaged foods company positioned for sustainable,
profitable growth with the completion of our acquisition of SweetWater late in
the second quarter. In addition to advancing our long-term vision and growth
objectives, the addition of SweetWater is a cornerstone within our U.S.
strategy and a strong complement to our existing Aphria business that we
believe will return compelling financial benefits. We already hit the ground
running by starting to build upon the strengths of each of our respective
complementary cannabis lifestyle brands broadening our consumer reach and
enhancing loyalty with existing consumers."
Simon continued, "We remain
excited about our recently announced definitive agreement with Tilray to
combine to create the largest global cannabis company and are on-track to close
the transaction in the second quarter of calendar year 2021. At Aphria, we
continue to build on our strong foundation in Canada and internationally to
capitalize on growth opportunities utilizing our best-in-class cultivation and
manufacturing across a greater distribution footprint and enabling us to
connect with an increasing number of consumers and patients with our
industry-leading brands and diversified product offerings. Looking forward, we are planning to execute
on the significant strategic and financial opportunities provided by the
addition of SweetWater and, upon the closing of the Tilray business
combination, including our over $100 million anticipated pre-tax synergies, to
generate significant value for our stakeholders."
Namaste
Technologies Inc. (TSXV:
N)
(OTC:
NXTTF), a leading platform for cannabis products,
accessories, and education, announced,
subject to Exchange approval, further expansion into the USA via CannMart.com
with sales of hemp derived CBD. The Company looks forward to leveraging
VendorLink, it's marketplace technology, in collaboration with PeakBirch Logic,
Inc.
The Company previously announced
subject to Exchange approval, through an appropriate affiliate, the sale of
accessories in the USA as permissible under state laws. The announcement of
this further expansion in the USA underscores Namaste's intention to increase
its total addressable market and exploration into other verticals as regulation
evolves and other adjacent complementary market opportunities present
themselves. The Company is targeting a go-live date for USA customers at
CannMart.com by the end of this fiscal quarter.
"We first announced our 24
month collaboration arrangement with PeakBirch in September, 2020 including the
possible development of business in the USA and we are delighted to see the
first fruits of that collaboration today," said Meni Morim, CEO of
Namaste. "With the changing regulatory landscape improving in the USA, our
recent announced proposed entry into the USA through the sale of accessories
fulfilled by DankStop, and now this proposed entry into the U.S. hemp derived
CBD market, we continue the execution of our strategy to position Namaste as a
leading global cannabis company and look forward to building on this positive
momentum. This development also further validates our investment in technology,
as the proposed expansion will be facilitated via our marketplace technology
and we are looking forward to launching more vendors onto the platform."
"We are delighted to
collaborate with Namaste and join their VendorLink platform to offer hemp
derived CBD in the USA at CannMart.com," said Marc Mulvaney, CEO of
PeakBirch. "We see great potential in the marketplace to open up our
brands to new customers in the USA."
Mr. Meni Morim, CEO will be
presenting at the NobleCon17 investor conference on Wednesday, January 20th at
3:45 p.m. EST, discussing this new opportunity and the Company's USA expansion.
The conference this year is virtual, with no cost, obligation or restrictions
to attend: www.noblecon17.com.
The
Valens Company Inc. (TSX:
VLNS) (OTCQX:
VLNCF)
announced today that it has become an Associate Corporate
Member of Food, Health & Consumer Products of Canada (FHCP), the largest
voice of the Canadian food, beverage and consumer products industry
representing small independently and privately-owned companies as well as
large, global multinationals, all of whom manufacture and distribute safe and
high-quality consumer packaged goods (CPG) in Canada.
As the leading voice uniting
companies, large and small, that provide access to the food, health, and
consumer products that Canadians rely on every day, FHCP works to create a
favourable business environment that allows its members to bring innovative
products to market, promotes environmental stewardship, and standardizes
product labelling so that Canadians have choices and ready access to
world-leading safe and high-quality products.
Joining FHCP is a natural progression
for Valens in establishing a broader CPG footprint and bringing about efforts
to normalize cannabinoid products, which now include various health and
wellness formats such as beverages and bath and beauty products, beyond what
current consumers expect.
"As the only cannabis company
in FHCP, our aim is to build out the category using data-driven consumer
insights and respond to consumer needs in medical, recreational as well as
health and wellness segments," said Tyler Robson, Chief Executive Officer
of The Valens Company. "With Cannabis 2.0 and now Cannabis 3.0 products
entering the market, we are working to create space within the CPG category
where cannabis is part of the conversation. Consumers are already there, which
just makes our membership with the FHCP a natural fit to their work and
mission."
The relationship with FHCP will
allow Valens the opportunity to create strategic category-building connections
with over one hundred of Canada's top CPG companies while allowing the Company
to educate FHCP members about the benefits of not only major but also minor,
non-intoxicating cannabinoids. As a member, The Valens Company will have
opportunities to work with CPG peers and facilitate discussion through
seminars, workshops, and presentations. The Company will also rely on its
extensive experience in cannabinoid research, product development, and
large-scale manufacturing, and work with FHCP to develop consumer and trade
insights for companies looking to learn more about the cannabis industry.
"Our mission at FHCP is to
create and shape a competitive operating environment that fosters innovation
and growth for our members, which includes developing categories such as
high-quality cannabinoid-based products," said Michael Graydon, Chief
Executive Officer of FHCP. "Valens' membership will serve both to educate
our members as well as bring cannabis and cannabis products into the
conversation when it comes to things like policy discussions, safety and
standards, and we're excited to have them on board."
Pure Extracts Technologies Corp. (CSE:
PULL) (OTC:
PRXTF) announced that it
has delineated the timetable and milestones for its study on the formulation
and manufacturing of psilocybin based active treatments for oral tablets,
capsules and a nasal gel that will be used as an investigational product. The
study with be conducted at the Toronto Institute of Pharmaceutical Technology
by Dr. Alexander MacGregor, a key scientific advisor to the Company.
The
study will focus on formulating, manufacturing and clinical bioavailability
testing of rapid onset psilocybin dosage forms that could be used in future
efficacy clinical trials by both Pure Extracts and its pharmaceutical
customers. Clinical batch manufacturing, packaging and labelling are all
included in the study as is conformity testing and stability testing (including
both long-term and accelerated). The study will conform to both Canadian Good
Manufacturing Practice (“GMP”) and Good Clinical Practice (“GCP”) standards.
The key
milestones in the 250-day timeline for the study on psilocybin immediate
release tablets and nasal gel include the following:
● Sourcing
and procurement of medicinal ingredients, excipients & packaging materials
● Raw
Material Testing
● Formulation
and Manufacturing Process Development, Stability Testing
● Clinical
Batch Manufacturing
● Quality
Control Release Testing
● Shipping
of Clinical Batches to CRO
Pure
Extracts CEO, Ben Nikolaevsky, remarked, “We are excited about the R&D
progress we are going to make with TIPT over the next 6 – 8 months while
waiting to receive our Dealer’s License from Health Canada. We will be well
prepared for our move into the controlled substances world of psychedelics and
will have advanced knowledge regarding psilocybin and its associated novel
delivery mechanisms.”
Investor ideas reminds all
listeners to read our disclaimers and disclosures on the Investorideas.com
website and that this podcast is not an endorsement to buy products or services
or securities. Investors are reminded all investment involves risk and possible
loss of investment.
Learn more about
our cannabis podcasts at https://www.investorideas.com/Audio/Potcasts.asp
Investors can
trade these stocks and other ideas on our site
using our list of top stock trading apps
including Robinhood , Acorn, Stash and
others.
To hear more
Investorideas.com podcasts visit: https://www.investorideas.com/Audio/.
Investorideas.com
podcasts are also available on iTunes,
Spotify, Google Play Music, Stitcher, Spreaker, YouTube via Spreaker, iHeartradio and Tunein.
Potcasts is now a certified
word mark Trademark on the blockchain through Cognate, Inc. CM
Certification-Registration Number: 10468217708
About Investorideas.com - News that
Inspires Big Investing Ideas
Investorideas.com
is a recognized news source publishing third party news, research and original
financial content. Learn about investing in stocks and sector trends with our
news alerts, articles, podcasts and
videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water,
renewable energy and more. Investor Idea’s original branded content includes
the following podcasts and columns : Crypto Corner , Play
by Play sports and stock news column, Investor Ideas
Potcasts Cannabis News and Stocks on the Move podcast and
column, Cleantech
and Climate Change , Exploring
Mining the AI
Eye .
Disclaimer/Disclosure: Investorideas.com is a
digital publisher of third party sourced news, articles and equity research as
well as creates original content, including video, interviews and articles.
Original content created by investorideas is protected by copyright laws other
than syndication rights. Our site does not make recommendations for purchases
or sale of stocks, services or products. Nothing on our sites should be
construed as an offer or solicitation to buy or sell products or securities.
All investing involves risk and possible losses. This site is currently
compensated for news publication and distribution, social media and marketing,
content creation and more. Disclosure is posted for each compensated news
release, content published /created if required but otherwise the news was not
compensated for and was published for the sole interest of our readers and
followers. Contact management and IR of each company directly regarding
specific questions. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other
news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com
Global investors must adhere to regulations
of each country. Please read Investorideas.com privacy policy:
https://www.investorideas.com/About/Private_Policy.asp
Investor Ideas does not condone the use of
cannabis except where permissible by law. Our site does not possess,
distribute, or sell cannabis products.
Follow us on Twitter https://twitter.com/Investorideas
Follow
us on Facebook https://www.facebook.com/Investorideas
Follow
us on YouTube https://www.youtube.com/c/Investorideas
Download
our Mobile App for
iPhone and Android
Join
our Investor Club https://www.investorideas.com/membership/
Contact Investorideas.com
800
665 0411
Get more Cannabis Stock Investor Ideas – news,
articles, podcasts and
stock directory
